First Ascent Biomedical, a Miami, FL-based company which specializes in personalized cancer treatments, raised $6M in funding.
Backers included Vidal Duart Enterprises, Inc., with an additional co-investment from Techstars.
The company intends to use the funds for the expansion of its operations, including the establishment of a lab in Florida.
Led by CEO Jim Foote, First Ascent Biomedical specializes in functional precision medicine, leveraging advanced technologies to personalize cancer treatment. With roots in Florida and a commitment to improving patient outcomes, its platform integrates drug testing, DNA/RNA sequencing and AI-guided tumor weakness mapping to test hundreds of FDA-approved drugs against a patient’s cancer profile. It also delivers an actionable plan to a patient’s physician in an average of 10 days.
FinSMEs
14/01/2025